• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌细胞代谢将表观遗传修饰与转录调控联系起来。

Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.

机构信息

Department of Biology, Stanford University, Stanford, CA, USA.

出版信息

FEBS J. 2022 Mar;289(5):1302-1314. doi: 10.1111/febs.16032. Epub 2021 Jun 11.

DOI:10.1111/febs.16032
PMID:34036737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613311/
Abstract

Adaptation of cellular function with the nutrient environment is essential for survival. Failure to adapt can lead to cell death and/or disease. Indeed, energy metabolism alterations are a major contributing factor for many pathologies, including cancer, cardiovascular disease, and diabetes. In particular, a primary characteristic of cancer cells is altered metabolism that promotes survival and proliferation even in the presence of limited nutrients. Interestingly, recent studies demonstrate that metabolic pathways produce intermediary metabolites that directly influence epigenetic modifications in the genome. Emerging evidence demonstrates that metabolic processes in cancer cells fuel malignant growth, in part, through epigenetic regulation of gene expression programs important for proliferation and adaptive survival. In this review, recent progress toward understanding the relationship of cancer cell metabolism, epigenetic modification, and transcriptional regulation will be discussed. Specifically, the need for adaptive cell metabolism and its modulation in cancer cells will be introduced. Current knowledge on the emerging field of metabolite production and epigenetic modification will also be reviewed. Alterations of DNA (de)methylation, histone modifications, such as (de)methylation and (de)acylation, as well as chromatin remodeling, will be discussed in the context of cancer cell metabolism. Finally, how these epigenetic alterations contribute to cancer cell phenotypes will be summarized. Collectively, these studies reveal that both metabolic and epigenetic pathways in cancer cells are closely linked, representing multiple opportunities to therapeutically target the unique features of malignant growth.

摘要

细胞功能与营养环境的适应对于生存至关重要。如果不能适应,就会导致细胞死亡和/或疾病。事实上,能量代谢的改变是许多病理学的一个主要因素,包括癌症、心血管疾病和糖尿病。特别是,癌细胞的一个主要特征是代谢改变,即使在有限的营养物质存在的情况下,也能促进存活和增殖。有趣的是,最近的研究表明,代谢途径产生的中间代谢产物直接影响基因组中的表观遗传修饰。新出现的证据表明,癌细胞的代谢过程通过对增殖和适应性存活至关重要的基因表达程序的表观遗传调控,在一定程度上推动了恶性生长。在这篇综述中,将讨论近年来人们对癌细胞代谢、表观遗传修饰和转录调控之间关系的理解所取得的进展。具体来说,将介绍癌细胞代谢适应性及其在癌细胞中的调节的必要性。还将回顾代谢物产生和表观遗传修饰这一新兴领域的现有知识。将在癌细胞代谢的背景下讨论 DNA(去)甲基化、组蛋白修饰(如去甲基化和去乙酰化)以及染色质重塑的改变。最后,将总结这些表观遗传改变如何导致癌细胞表型。总的来说,这些研究表明,癌细胞中的代谢和表观遗传途径密切相关,为针对恶性生长的独特特征进行治疗提供了多种机会。

相似文献

1
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.癌细胞代谢将表观遗传修饰与转录调控联系起来。
FEBS J. 2022 Mar;289(5):1302-1314. doi: 10.1111/febs.16032. Epub 2021 Jun 11.
2
Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.分子途径:癌症中组蛋白甲基化和基因表达的代谢调控
Clin Cancer Res. 2017 Aug 1;23(15):4004-4009. doi: 10.1158/1078-0432.CCR-16-2506. Epub 2017 Apr 12.
3
Cancer epigenetics: promises and pitfalls for cancer therapy.癌症表观遗传学:癌症治疗的希望与陷阱。
FEBS J. 2022 Mar;289(5):1156-1159. doi: 10.1111/febs.16395.
4
Clinical advances in targeting epigenetics for cancer therapy.癌症治疗中靶向表观遗传学的临床进展。
FEBS J. 2022 Mar;289(5):1214-1239. doi: 10.1111/febs.15750. Epub 2021 Feb 18.
5
Connections between metabolism and epigenetics in cancers.癌症中代谢与表观遗传学的联系。
Semin Cancer Biol. 2019 Aug;57:52-58. doi: 10.1016/j.semcancer.2019.06.006. Epub 2019 Jun 8.
6
Metabolic Signaling to the Nucleus in Cancer.癌症中的代谢信号转导至细胞核
Mol Cell. 2018 Aug 2;71(3):398-408. doi: 10.1016/j.molcel.2018.07.015.
7
Therapeutic targeting of chromatin: status and opportunities.靶向染色质治疗:现状与机遇。
FEBS J. 2022 Mar;289(5):1276-1301. doi: 10.1111/febs.15966. Epub 2021 Jun 25.
8
Oncohistones: a roadmap to stalled development.癌组蛋白:停滞发展的路线图。
FEBS J. 2022 Mar;289(5):1315-1328. doi: 10.1111/febs.15963. Epub 2021 May 24.
9
Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy.叛逆的表观基因组:组蛋白 H3S10 磷酸化和 H3S10 激酶在癌症生物学和治疗中的作用。
Clin Epigenetics. 2020 Oct 14;12(1):147. doi: 10.1186/s13148-020-00941-2.
10
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance.肿瘤发生中的表观遗传机制、肿瘤细胞异质性和耐药性。
Drug Resist Updat. 2012 Feb-Apr;15(1-2):21-38. doi: 10.1016/j.drup.2012.01.008. Epub 2012 Feb 20.

引用本文的文献

1
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancer.OGDHL调节前列腺癌中的核苷酸代谢、肿瘤生长和神经内分泌标志物表达。
bioRxiv. 2025 Jun 1:2025.05.28.656673. doi: 10.1101/2025.05.28.656673.
2
Mitochondrial DNA copy number alterations: Key players in the complexity of glioblastoma (Review).线粒体DNA拷贝数改变:胶质母细胞瘤复杂性中的关键因素(综述)
Mol Med Rep. 2025 Mar;31(3). doi: 10.3892/mmr.2025.13443. Epub 2025 Jan 31.
3
E4F1 coordinates pyruvate metabolism and the activity of the elongator complex to ensure translation fidelity during brain development.E4F1协调丙酮酸代谢和延伸因子复合物的活性,以确保大脑发育过程中的翻译保真度。
Nat Commun. 2025 Jan 2;16(1):67. doi: 10.1038/s41467-024-55444-y.
4
Altered metabolism in cancer: insights into energy pathways and therapeutic targets.癌症中的代谢改变:能量途径和治疗靶点的新见解。
Mol Cancer. 2024 Sep 18;23(1):203. doi: 10.1186/s12943-024-02119-3.
5
Sensitive Detection of Histones and γ-H2AX by Immunoblotting: Problems and Solutions.通过免疫印迹法灵敏检测组蛋白和γ-H2AX:问题与解决方案
Chem Res Toxicol. 2024 Sep 16;37(9):1588-1597. doi: 10.1021/acs.chemrestox.4c00307. Epub 2024 Sep 5.
6
Mitochondrial Alpha-Keto Acid Dehydrogenase Complexes: Recent Developments on Structure and Function in Health and Disease.线粒体 α-酮酸脱氢酶复合物:在健康和疾病中的结构和功能的最新进展。
Subcell Biochem. 2024;104:295-381. doi: 10.1007/978-3-031-58843-3_13.
7
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance.乳腺癌治疗耐药性中表观遗传-代谢调控轴的多棱镜观点。
Oncogene. 2024 Jun;43(23):1727-1741. doi: 10.1038/s41388-024-03054-9. Epub 2024 May 8.
8
Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer.谷氨酰胺介导的 cFLIP 的表观遗传调控是胰腺癌对 TRAIL 耐药的基础。
Exp Mol Med. 2024 Apr;56(4):1013-1026. doi: 10.1038/s12276-024-01231-0. Epub 2024 Apr 30.
9
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention.补充谷氨酰胺作为一种抗癌策略:一种有潜力的传统治疗替代方法。
Cancers (Basel). 2024 Mar 5;16(5):1057. doi: 10.3390/cancers16051057.
10
Social determinants of health, the microbiome, and surgical injury.健康的社会决定因素、微生物组和手术损伤。
J Trauma Acute Care Surg. 2024 Jul 1;97(1):158-163. doi: 10.1097/TA.0000000000004298. Epub 2024 Mar 4.

本文引用的文献

1
Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment.饮食与肿瘤微环境交汇处的脂质代谢
Trends Cancer. 2019 Nov;5(11):693-703. doi: 10.1016/j.trecan.2019.09.007. Epub 2019 Oct 31.
2
Recognition of Histone Crotonylation by Taf14 Links Metabolic State to Gene Expression.组蛋白巴豆酰化的识别通过 Taf14 将代谢状态与基因表达联系起来。
Mol Cell. 2019 Dec 19;76(6):909-921.e3. doi: 10.1016/j.molcel.2019.09.029. Epub 2019 Oct 29.
3
The Impact of One Carbon Metabolism on Histone Methylation.一碳代谢对组蛋白甲基化的影响。
Front Genet. 2019 Aug 28;10:764. doi: 10.3389/fgene.2019.00764. eCollection 2019.
4
The diverse roles of DNA methylation in mammalian development and disease.DNA 甲基化在哺乳动物发育和疾病中的多种作用。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):590-607. doi: 10.1038/s41580-019-0159-6. Epub 2019 Aug 9.
5
The roles of DNA, RNA and histone methylation in ageing and cancer.DNA、RNA 和组蛋白甲基化在衰老和癌症中的作用。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):573-589. doi: 10.1038/s41580-019-0143-1. Epub 2019 Jul 3.
6
The BAF complex in development and disease.BAF 复合物在发育和疾病中的作用。
Epigenetics Chromatin. 2019 Mar 21;12(1):19. doi: 10.1186/s13072-019-0264-y.
7
Lysine crotonylation is involved in hepatocellular carcinoma progression.赖氨酸丁酰化参与肝细胞癌的进展。
Biomed Pharmacother. 2019 Mar;111:976-982. doi: 10.1016/j.biopha.2018.12.148. Epub 2019 Jan 9.
8
Regulation of chromatin and gene expression by metabolic enzymes and metabolites.代谢酶和代谢产物对染色质和基因表达的调控。
Nat Rev Mol Cell Biol. 2018 Sep;19(9):563-578. doi: 10.1038/s41580-018-0029-7.
9
The INO80 chromatin remodeler sustains metabolic stability by promoting TOR signaling and regulating histone acetylation.INO80 染色质重塑复合物通过促进 TOR 信号和调节组蛋白乙酰化来维持代谢稳定性。
PLoS Genet. 2018 Feb 20;14(2):e1007216. doi: 10.1371/journal.pgen.1007216. eCollection 2018 Feb.
10
INO80 haploinsufficiency inhibits colon cancer tumorigenesis via replication stress-induced apoptosis.INO80单倍剂量不足通过复制应激诱导的凋亡抑制结肠癌的肿瘤发生。
Oncotarget. 2017 Dec 6;8(70):115041-115053. doi: 10.18632/oncotarget.22984. eCollection 2017 Dec 29.